Telix is in a strong financial position with net cash of AUD 140 million as of December 2024. We forecast free cash flow averaging 87% of net income over the next 10 years, and in the absence of major ...

Chimerix holds the potential to have the first approval of dordaviprone for treating recurrent H3 K27M mutant high-grade ...

Immune therapy has transformed how cancer is treated, but many tumors continue to evade these treatments, thanks to their resemblance to healthy tissue.

Clinical research suggests that combining a novel agent called navtemadlin with DNA-damaging chemotherapy for the treatment of glioblastoma, a form of brain cancer, could increase efficacy.

Protecting firefighters from occupational cancer risks, electric vehicle fires associated with higher cancer risks, ...

Human health is strongly intertwined with the health of the microbiome. A large number of studies have shown that the human ...

During a live event, Alexander I. Spira, MD, PhD, and participants NGS testing practices and the rationale behind their ...

Immune therapy has transformed how cancer is treated, but many tumors continue to evade these treatments, thanks to their ...

The question of how to care for incarcerated patients in hospitals is an urgent one. We can’t afford to get it wrong.

During a Case-Based Roundtable® event, Julie R. Brahmer, MD, MSC, reviewed the CheckMate 9LA, KEYNOTE-407, and POSEIDON ...